Alzheimers News & Features

The FDA has cleared the first in vitro diagnostic test for early detection of Alzheimer's disease.

A large new study finds Black, Hispanic and Asian Americans have an increased risk of being diagnosed with dementia, but the reasons why are unclear.

Early research suggests a type of RA drug known as TNF inhibitors may lower dementia risk in people who have RA and heart disease.

Federal officials have made their final decision: Medicare will only pay for patients to get the new Alzheimer's drug aducanumab (Aduhelm) if the patients are participating in clinical trials.

A new study finds education and language skills can help predict who will go on to develop dementia and who won't.

researchers found that those taking Viagra were 69% less likely to develop Alzheimer's, when compared to non-users. And lab experiments showed that the medication seemed to target part of the underlying disease process in Alzheimer's.

The vaccine stimulates the immune system, prompting white blood cells to migrate to the brain and clear beta amyloid plaques.

New research suggests a diet is loaded with pro-inflammatory foods may increase your risk for memory loss, issues with language, problem-solving and other thinking skills as you age.

A new study suggests that if you're depressed as a young adult, your odds for dementia rise.

A new study suggests older adults who take certain diabetes drugs may see a slower decline in their memory and thinking skills.

A long-term study links exposure to higher levels of fine particulate air pollution to an increased risk of dementia.

Studies show the drug Riluzole which is used to slow the progression of ALS may have positive effects on cognition in people with mild Alzheimer's.

Medicare launched a formal process that will determine whether the agency will cover Aduhelm, the newly approved Alzheimer's drug whose high price tag and unproven benefits have prompted widespread controversy.

Following the FDA’s controversial approval of aducanumab for Alzheimer's, the head of the agency is now calling for a federal investigation into its own approval proceedings.

As advocates and critics debate the FDA's approval of the new drug, and a chorus of experts and patient advocates protest the price, many patients and their families are excited about it, hopeful that it will stop the debilitating disease from getting worse .

A consumer advocacy group is calling for the removal of three top FDA officials, saying the agency's approval of the Alzheimer's drug aducanumab (Aduhelm) was "reckless."

A man has received the first infusion of a new Alzheimer’s drug that drew criticism from some doctors after its FDA approval last week.

As the first Alzheimer's drug approved since 2003, advocates applaud the decision. Critics say the approval was based on inadequate proof that the drug works and balk at the price tag of $56,000 a year.

The drug, aducanumab, has had a rocky road to FDA approval, including a vote by an advisory committee to reject it.

The study adds to growing evidence that exposure to pollutants and chemicals in the environment plays an important role in the development of Parkinson’s, a disease of the nervous system that makes people less able to control body movements.

Short sleepers in midlife have an increased risk for dementia, independent of mental health and other factors, highlighting the importance of sleep for brain health, new research shows.

The family of famed animal expert Jack Hanna says he has been diagnosed with dementia which is in an advanced state.

It can be hard to talk with your loved one if they believe things that aren’t true. But the right skills can help you communicate with someone who has dementia-related psychosis.

There’s no cure for dementia-related psychosis. But there are steps you can take to help you and your loved one live with the disease and its symptoms.

Psychotic episodes -- like hallucinations or delusions -- related to dementia can be scary for all involved. But there are ways to diagnose and treat the condition.